Epidural Injection With or Without Steroid For Low Back Pain

Efficacy Of Interlaminar Epidural Injection With or Without Steroid For Low Back Pain Due To Lumbar Canal Stenosis: A Randomised Double Blind Study. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069051

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G892- Chronic pain, not elsewhere classified

Interventions

Intervention1: INTERLAMINAR EPIDURAL INJECTION: epidural injection with steroid: Ropivacaine (0.2%) 5ml + Triamcinolone 40 mg (1 ml) Control Intervention1: INTERLAMINAR EPIDURAL INJECTION: epidural i

Eligibility

Inclusion criteria

Inclusion criteria: Patients having chronic lower back pain due lumbar canal stenosis as evident from radiological findings on MRI.

Exclusion criteria

Exclusion criteria: Patients with- 1) Contraindication to the procedure (active, local or systemic infections), coagulopathy, use of anti thrombotic or anti platelet medications. 2) History of allergy to contrast medium or injected medication. 3)Previous history of low back surgery. 4)Lower Back Pain due to PIVD. 5)Pre-existing uncontrolled hypertension, uncontrolled diabetes mellitus type 2.

Design outcomes

Primary

Measure	Time frame
To evaluate and compare the efficacy of lumbar interlaminar epidural injection (ILEI) with following parameters in both the groups: a)Reduction of pain by visual analogue scale (VAS) at 1, 3 and 6 months. b)Improvement of functional status by walking distance and Revised Oswestry Disability Index at 1, 3 and 6 months. Timepoint: a)Reduction of pain by visual analogue scale (VAS) at 1, 3 and 6 months. b)Improvement of functional status by walking distance and Revised Oswestry Disability Index at 1, 3 and 6 months.	—

Measure

Time frame

To evaluate and compare the efficacy of lumbar interlaminar epidural injection (ILEI) with following parameters in both the groups: a)Reduction of pain by visual analogue scale (VAS) at 1, 3 and 6 months. b)Improvement of functional status by walking distance and Revised Oswestry Disability Index at 1, 3 and 6 months. Timepoint: a)Reduction of pain by visual analogue scale (VAS) at 1, 3 and 6 months. b)Improvement of functional status by walking distance and Revised Oswestry Disability Index at 1, 3 and 6 months.

—

Secondary

Measure	Time frame
To compare the following parameters in both groups: a) Requirement of repeat ILEI. b) Adverse effects (PDPH, hypotension, bradycardia, nausea/vomiting, vasovagal reaction intrathecal/intravascular injection, allergic reactions etc.) Timepoint: At 4 weeks , 12 weeks & 48 Weeks	—

Countries

India

Contacts

Public ContactDR ANIL KUMAR BHIWAL

GEETANJALI MEDICAL COLLEGE AND HOSPITAL

anilbhiwal@yahoo.co.in9799185525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026